Search
Find a recruiting study
7,114 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 28, 2026). No sign-up needed.
Most recently updated studies · page 96 of 297
- RecruitingPhase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
Denali Therapeutics Inc.
- Location
- Irvine, CA + 3 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
Macro Biologics, Inc.
- Location
- Torrance, CA + 4 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Descartes-08 in Autoantibody Myositis
Cartesian Therapeutics
- Location
- Orange, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
GlaxoSmithKline
- Location
- Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
xDot Access Management System Early Feasibility Study
xDot Medical, Inc
- Location
- Downers Grove, IL + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Novo Nordisk A/S
- Location
- Escondido, CA + 17 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
VDyne, Inc.
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Phase 1 Study of C.001 in Retinal Degeneration
Cellio Therapeutics Inc
- Location
- Beverly Hills, CA
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Alkermes, Inc.
- Location
- Dothan, AL + 14 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Tucson, AZ + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
AbbVie
- Location
- Huntsville, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Home-Based tDCS Treatment Of Major Depressive Disorder
Sooma Medical Inc
- Location
- Boston, MA
- Eligibility basics
- Ages 22–70
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Anniston, AL + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva GmbH
- Location
- Murrieta, CA + 6 other US sites
- Eligibility basics
- Ages 55–90
- Recruiting
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
MediBeacon
- Location
- New York, NY
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Takeda
- Location
- Scottsdale, AZ
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Oculis
- Location
- Livonia, MI + 3 other US sites
- Eligibility basics
- Ages 18–50
- RecruitingPhase 2
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
Galderma R&D
- Location
- San Antonio, TX
- Eligibility basics
- Ages 6 mo–1
- RecruitingPhase 3
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Gilead Sciences
- Location
- San Francisco, CA + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
AstraZeneca
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 1/Phase 2
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
AviadoBio Ltd
- Location
- Columbus, OH + 2 other US sites
- Eligibility basics
- Ages 30–75
- RecruitingPhase 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Claris Biotherapeutics, Inc.
- Location
- Loma Linda, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
BioMendics, LLC
- Location
- Palo Alto, CA + 1 other US site
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 6–17
Data source: daily sync of the ClinicalTrials.gov API. How we list studies